Stock OXMDGG MEDIGENE NA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar MEDIGENE NA Swiss Exchange

Equities

OXMDGG

DE0005020903

End-of-day quote Swiss Exchange
Other stock markets
- EUR - Intraday chart for MEDIGENE NA
05-21 Medigene, BioNTech Extend Cancer Immunotherapy Partnership MT
05-21 Medigene AG's Global Research & Collaboration Agreement with BioNTech SE to Extend Beyond Initial Announced Term CI

Chart calendar MEDIGENE NA

3fb929ba0250fd.TZCx5ytmGhCqfdKJ82ha4jX2rNdmg-0jKZ3GaVbhFsc.PvHzlBwudX_bGOu8rF0ekFOU6bYqtK9FQv6DJR-Nfa0U-tOqGQgqfcNQlw~0d2e6d69ba15d1e552ce2f9295f7a3ea

Upcoming events on MEDIGENE NA

2024-06-23 Annual General Meeting
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-13 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)

Past events on MEDIGENE NA

2024-05-21 09:00 Benchmark Healthcare House Virtual Conference
2024-05-15 09:00 CIMT Meeting - Abstract Number 3
2024-05-15 09:00 Association for Cancer Immunotherapy Meeting - Abstract Number: 3
2024-05-01 06:00 Neoantigen International Summit
2024-04-26 03:00 Q1 2024 Earnings Release
2024-04-25 08:15 Europe CHI Immuno- Oncology Summit
2024-04-23 Rights Issue: 1 new share @ 1.2 EUR for 5 existing shares
2024-04-07 16:30 American Association for Cancer Research Meeting
2024-03-28 10:00 Q4 2023 Earnings Call
2024-03-28 02:30 Q4 2023 Earnings Release
2024-03-25 H.C. Wainwright Cell Therapy Virtual Conference
2024-03-07 14:10 ELRIG Forum
2024-03-04 East-West Biopharma Summit
2024-02-28 12:30 CAR-TCR Europe Summit
2024-02-28 07:30 CAR-TCR Europe Summit - Panel
2024-01-07 JPMorgan Healthcare Conference
2023-11-27 08:05 Deutsches Eigenkapital Forum
2023-11-05 Bio-Europe Conference
2023-11-04 12:00 Society for Immunotherapy of Cancer Meeting - Abstract number: 388
2023-10-26 02:30 Q3 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		10,6
7,95
33.74%		8,75
8,43
3.85%		10,5
9,40
11.31%		0,00


6,03
5,50
9.71%
10,6

EBITDA
Million EUR		Released
Forecast
Spread 		-17,8
-24,0
25.88%		-22,2
-22,0
-0.93%		-6,56
-11,7
43.96%		0,00


-14,7
-18,1
18.86%
-11,8

EBIT
Million EUR		Released
Forecast
Spread 		-20,2
-27,0
25.33%		-28,7
-23,3
-22.93%		-9,99
-11,7
14.73%		0,00


-16,1
-18,8
13.87%
-11,8

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-19,9
-26,3
24.27%		-28,4
-24,6
-15.63%		-10,3
-14,0
26.55%		0,00


-16,6
-19,4
14.25%
-11,7

Net income
Million EUR		Released
Forecast
Spread 		-20,0
-26,3
24.1%		-28,9
-22,8
-26.48%		-9,98
-14,0
28.69%		-8,33


-16,2
-18,9
14.18%
-11,7

EPS
EUR		Released
Forecast
Spread 		-0,81
-1,09
25.69%		-1,18
-0,93
-27.57%		-0,41
-0,48
14.58%		-0,34


-0,66
-0,79
16.46%
-0,37

Announcement Date26/03/2025/03/2123/03/2229/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million EUR		Released
Forecast
Spread 		1,55
0,00
- 		3,06
0,00
- 		2,97
2,74
8.39%
4,15


6,85

EBITDA
Million EUR		Released
Forecast
Spread
-6,48

-6,62
-12,7
47.8%		-8,07
-11,4
29.25%
-7,20


-4,60

EBIT
Million EUR		Released
Forecast
Spread 		-4,12


-7,37


-8,78
-11,4
23.01%
-7,20


-4,60

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-4,26
-6,02
29.34%		-7,70
-11,6
33.55%		-8,89
-11,7
23.99%
-7,10


-4,50

Net income
Million EUR		Released
Forecast
Spread 		-4,06
-6,02
32.61%		-6,97
-11,6
39.85%		-9,21
-12,5
26.34%
-7,10


-4,50

EPS
EUR		Released
Forecast
Spread 		-0,17
-0,74
77%		-0,28
-1,44
80.58%		-0,38
-0,51
25.49%
-0,28


-0,12

Announcement Date17/08/2317/08/2328/03/24--

Upcoming sector events for MEDIGENE NA

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for MEDIGENE NA

2024-06-05 03:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 16:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 16:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. MDG1 Stock
  4. OXMDGG Stock
  5. Calendar MEDIGENE NA